Change in albuminuria as a surrogate endpoint in chronic kidney disease

被引：2
|
作者：
Pyne, Lonnie [1 ,2 ]
Guyatt, Gordon H. [1 ,2 ]
Walsh, Michael [1 ,2 ,3 ,4 ]
机构：
[1] McMaster Univ, Dept Med, Hamilton, ON LN8 3Z5, Canada
[2] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON LN8 3Z5, Canada
[3] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada
[4] McMaster Univ, Hamilton, ON, Canada
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2019年 / 7卷 / 05期
关键词：
D O I：
10.1016/S2213-8587(19)30089-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：335 / 335
页数：1
相关论文
共 50 条
  • [1] Change in albuminuria as a surrogate endpoint in chronic kidney disease reply
    Heerspink, Hiddo J. L.
    Coresh, Josef
    Gansevoort, Ron T.
    Inker, Lesley A.
    LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (05): : 336 - 337
  • [2] Change in albuminuria as a surrogate endpoint
    Waijer, Simke W.
    Gansevoort, Ron T.
    Heerspink, Hiddo J. L.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2019, 28 (06): : 519 - 526
  • [3] Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials
    Heerspink, Hiddoj L.
    Greene, Tom
    Tighiouart, Hocine
    Gansevoort, Ron T.
    Coresh, Josef
    Simon, Andrew L.
    Chan, Tak Mao
    Hou, Fan Fan
    Lewis, Julia B.
    Locatelli, Francesco
    Praga, Manuel
    Schena, Francesco Paolo
    Levey, Andrew S.
    Inker, Lesley A.
    Schrier, Robert W.
    Estacio, Raymond O.
    Perkovic, Vlado
    Parving, Hans-Henrik
    Carlo, Manno
    Zucchelli, Pietro
    Brenner, Barry M.
    Barret, Brendan
    Kamper, Anne-Lise
    Strandgaard, Svend
    Rodby, Roger A.
    Rohde, Richard D.
    Lewis, Edmund
    Wanner, Christoph
    von Eynatten, Maximilian
    Katafuchi, Ritsuko
    de Jong, Paul E.
    van Essen, G. G.
    Xie, Di
    Perrone, Ronald D.
    Abebe, Kaleab Z.
    Li, Philip
    Leung, C. B.
    Szeto, C. C.
    Chow, K. M.
    Del Vecchio, Lucia
    Andrulli, Simeone
    Pozzi, Claudio
    Maes, Bart
    Dwyer, Jamie
    Lachin, John M.
    Goicoechea, Marian
    Verde, Eduardo
    Caravaca, Fernando
    Gutierrez, Eduardo
    Sevillano, Angel
    LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (02): : 128 - 139
  • [4] Change in albuminuria as a surrogate endpoint for cardiovascular and renal outcomes in patients with diabetes
    Palmer, Biff F.
    DIABETES OBESITY & METABOLISM, 2023, 25 (06): : 1434 - 1443
  • [5] eGFR slope as a surrogate endpoint for clinical study in early stage of chronic kidney disease: from The Japan Chronic Kidney Disease Database
    Itano, Seiji
    Kanda, Eiichiro
    Nagasu, Hajime
    Nangaku, Masaomi
    Kashihara, Naoki
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2023, 27 (10) : 847 - 856
  • [6] eGFR slope as a surrogate endpoint for clinical study in early stage of chronic kidney disease: from The Japan Chronic Kidney Disease Database
    Seiji Itano
    Eiichiro Kanda
    Hajime Nagasu
    Masaomi Nangaku
    Naoki Kashihara
    Clinical and Experimental Nephrology, 2023, 27 : 847 - 856
  • [7] Chronic Kidney Disease and Albuminuria in Arterial Hypertension
    Leoncini, Giovanna
    Viazzi, Francesca
    Pontremoli, Roberto
    CURRENT HYPERTENSION REPORTS, 2010, 12 (05) : 335 - 341
  • [8] An update on albuminuria as a Chronic Kidney Disease marker
    Delanghe, J.
    CLINICA CHIMICA ACTA, 2024, 558
  • [9] Chronic Kidney Disease and Albuminuria in Arterial Hypertension
    Giovanna Leoncini
    Francesca Viazzi
    Roberto Pontremoli
    Current Hypertension Reports, 2010, 12 : 335 - 341
  • [10] Proteinuria versus albuminuria in chronic kidney disease
    Guh, Jinn-Yuh
    NEPHROLOGY, 2010, 15 : 53 - 56
12345